Recent News
Serpex Medical Announces Second FDA 510(k) Clearance of Its Steerable Endobronchial Instrument Platform - The Compass Steerable Needle
SANTA CLARA, Calif., Sept. 7, 2022 /PRNewswire/ -- Serpex Medical announced today U.S. FDA 510(k) clearance of its Compass Steerable Needles – steerable biopsy needles that enable precise access to lung nodules in the intrapulmonary region. Serpex Medical seeks to leverage the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer. The clearance of the Compass Steerable Needles follows the recent clearance of Serpex's Recon Steerable Sheath.
Serpex Medical Announces FDA Clearance of Steerable Sheath for Transbronchial Access
SANTA CLARA, Calif., Aug. 29, 2022 /PRNewswire/ -- Serpex Medical announced today U.S. FDA 510(k) clearance of its Recon Steerable Sheath – a steerable endobronchial tool that offers articulation at the distal tip to enable physicians to access difficult-to-reach areas of the lung anatomy. Serpex Medical seeks to leverage the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer. The Recon Steerable Sheath is the first device cleared in Serpex Medical's product portfolio of steerable instruments.
